Influence of inhibitors on the thrombogenicity and toxicity of prothrombin complex concentrates.
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D000991:Antithrombins / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use*; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors* / Q000633:toxicity; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D010426:Pentosan Sulfuric Polyester / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D013924:Thrombophlebitis / Q000139:chemically induced / Q000517:prevention & control*
D000925:Anticoagulants; D000991:Antithrombins; D001779:Blood Coagulation Factors; C025667:prothrombin complex concentrates; D010426:Pentosan Sulfuric Polyester; D006493:Heparin; D007611:Aprotinin